Back to top
more

BioTechne Corp (TECH)

(Delayed Data from NSDQ)

$75.96 USD

75.96
649,382

-0.46 (-0.60%)

Updated Nov 8, 2024 04:00 PM ET

After-Market: $75.96 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value C Growth B Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 31% (77 out of 250)

Industry: Medical - Biomedical and Genetics

Zacks News

PBYI or TECH: Which Is the Better Value Stock Right Now?

PBYI vs. TECH: Which Stock Is the Better Value Option?

PBYI or TECH: Which Is the Better Value Stock Right Now?

PBYI vs. TECH: Which Stock Is the Better Value Option?

PBYI vs. TECH: Which Stock Is the Better Value Option?

PBYI vs. TECH: Which Stock Is the Better Value Option?

PBYI or TECH: Which Is the Better Value Stock Right Now?

PBYI vs. TECH: Which Stock Is the Better Value Option?

Here's What Key Metrics Tell Us About Techne (TECH) Q1 Earnings

The headline numbers for Techne (TECH) give insight into how the company performed in the quarter ended September 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Techne (TECH) Q1 Earnings and Revenues Miss Estimates

Techne (TECH) delivered earnings and revenue surprises of -6.82% and 4.44%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?

BioMarin Pharmaceutical (BMRN) Reports Next Week: Wall Street Expects Earnings Growth

BioMarin (BMRN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Earnings Preview: Techne (TECH) Q1 Earnings Expected to Decline

Techne (TECH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

EXEL vs. TECH: Which Stock Is the Better Value Option?

EXEL vs. TECH: Which Stock Is the Better Value Option?

New Strong Sell Stocks for October 3rd

AFCG, AINC and TECH have been added to the Zacks Rank #5 (Strong Sell) List on October 3, 2023.

New Strong Sell Stocks for September 11th

AVTR, TECH and CPRI have been added to the Zacks Rank #5 (Strong Sell) List on September 11, 2023.

New Strong Sell Stocks for August 22nd

AVTR, BHLB and TECH have been added to the Zacks Rank #5 (Strong Sell) List on August 22, 2023.

Techne (TECH) Reports Q4 Earnings: What Key Metrics Have to Say

Although the revenue and EPS for Techne (TECH) give a sense of how its business performed in the quarter ended June 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Techne (TECH) Meets Q4 Earnings Estimates

Techne (TECH) delivered earnings and revenue surprises of 0% and 1.11%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

GSK or TECH: Which Is the Better Value Stock Right Now?

GSK vs. TECH: Which Stock Is the Better Value Option?

GSK vs. TECH: Which Stock Is the Better Value Option?

GSK vs. TECH: Which Stock Is the Better Value Option?

GSK vs. TECH: Which Stock Should Value Investors Buy Now?

GSK vs. TECH: Which Stock Is the Better Value Option?

PBYI or TECH: Which Is the Better Value Stock Right Now?

PBYI vs. TECH: Which Stock Is the Better Value Option?

PBYI vs. TECH: Which Stock Is the Better Value Option?

PBYI vs. TECH: Which Stock Is the Better Value Option?

Here's What Key Metrics Tell Us About Techne (TECH) Q3 Earnings

The headline numbers for Techne (TECH) give insight into how the company performed in the quarter ended March 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Techne (TECH) Meets Q3 Earnings Estimates

Techne (TECH) delivered earnings and revenue surprises of 0% and 0.74%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

GSK or TECH: Which Is the Better Value Stock Right Now?

GSK vs. TECH: Which Stock Is the Better Value Option?

Techne (TECH) Q2 Earnings and Revenues Miss Estimates

Techne (TECH) delivered earnings and revenue surprises of -4.08% and 6.34%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Analysts Estimate Illumina (ILMN) to Report a Decline in Earnings: What to Look Out for

Illumina (ILMN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Techne (TECH) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Techne (TECH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.